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13-cis Retinoic acid is rapidly absorbed into cells and
exerts its anti-proliferative effect on human sebocytes
by speci®c isomerization to high levels of all-trans
retinoic acid and binding the retinoic acid receptors.
In this study, we have shown that bovine serum
albumin, an extracellular binding protein for 13-cis
retinoic acid, plays an important part in the uptake
of 13-cis retinoic acid in human sebocytes, its intra-
cellular isomerization to all-trans retinoic acid, and
the induction of its anti-proliferative effect. The
addition of highly concentrated bovine serum albu-
min (20 mg per ml) to the serum-free maintenance
medium resulted in a rather controlled uptake of
constant levels of 13-cis and all-trans retinoic acid
into the cells over the 72 h of treatment. As a conse-
quence, signi®cantly reduced and delayed isomeriz-
ation of 13-cis retinoic acid to all-trans retinoic acid
was detected. In parallel experiments, the anti-pro-
liferative activity of 13-cis retinoic acid on SZ95
sebocytes was abrogated by adding 20 mg bovine
serum albumin per ml into the serum-free medium.
These results indicate a critical function of serum
albumin as retinoid-binding protein in reducing the
concentration of active retinoids and restricting their
biologic effects on human sebocytes. Key words: albu-
min/cell line/retinoids/sebaceous glands. J Invest Dermatol
119:182±185, 2002
R
etinoids are effectively transported in the blood-
stream bound to proteins (Smith et al, 1973),
whereas the plasma proteins involved are mainly
albumin for the acidic derivatives and lipoproteins
for the neutral compounds or esters (Urien et al,
1994). On the other hand, Hodam and Creek (1996) have shown
that the kinetics of uptake and metabolism of all-trans retinoic acid
(atRA) by human keratinocytes in vitro are strongly dependent on
whether atRA is added directly to the culture medium or delivered
bound to bovine serum albumin (BSA). The formation of an atRA-
BSA complex allowed a controlled cellular uptake of atRA in
comparison with rapid uptake and metabolism when atRA was
directly delivered to the cells or in medium containing low BSA
amounts. Like atRA, the 13-cis retinoic acid (13cRA)-albumin
complex was shown to exhibit a limited cellular uptake of 13cRA
and restricted anti-proliferative effects in small cell lung cancer cell
lines and the human promyelotic leukemia cell line HL-60 (Avis
et al, 1995; Mouawad et al, 1996).
In a previous study (Tsukada et al, 2000), it was shown that
13cRA exerts its speci®c activity on human sebocytes through a
quick and selective intracellular isomerization to atRA and binding
to retinoic acid receptors. The present study was conducted to
investigate the role of serum albumin excess in the magnitude of
cellular uptake, metabolism, and biologic effect of retinoic acids on
human sebocytes. SZ95 sebocytes were treated with 13cRA and
atRA in culture media containing high and low amounts of BSA. It
was found that high BSA amounts can reduce the intracellular
concentration of retinoic acids as well as the atRA/13cRA ratio
after 13cRA treatment and abrogate the anti-proliferative effect of
retinoic acids on human sebocytes.
MATERIALS AND METHODS
Culture of SZ95 sebocytes Immortalized human SZ95 sebocytes
(Zouboulis et al, 1999a) were maintained in a modi®ed Dulbecco's
modi®ed Eagle's medium/Ham's F12 medium (1:1) (Biochrom, Berlin,
Germany) with 2 mM N-acetyl-L-alanyl-L-glutamine, supplemented
with 10% heat-inactivated fetal bovine serum (Biochrom), and 50 mg
gentamycin per ml (Gibco-BRL, Karlsruhe, Germany) at 37°C in a
humidi®ed atmosphere containing 5% CO2. For high performance liquid
chromatography and proliferation studies, cells were incubated in the
same medium without serum but with 50 mg bovine pituitary extract per
ml and either 1 mg or 20 mg fatty acid-free (faf) BSA per ml
(Boehringer, Mannheim, Germany).
Treatment with retinoids 13cRA and atRA (purchased from Sigma-
Aldrich, Deisenhofen, Germany) were dissolved in dimethyl sulfoxide.
The ®nal concentration of dimethyl sulfoxide in medium was 0.2%.
Cells cultured in medium supplemented with dimethyl sulfoxide but
without retinoids served as controls. The retinoid compounds and the
cell cultures treated with retinoids were handled under dimmed yellow
light.
Solid-phase extraction and high performance liquid chromato-
graphy analysis Medium (6 ml) supplemented with retinoids (10±7 M)
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was added to con¯uent SZ95 sebocyte cultures in 100 mm culture dishes
(Falcon; Becton Dickinson, Heidelberg, Germany). After incubation for
different time lengths, the cell cultures were washed twice with
phosphate-buffered saline without Ca2+ and Mg2+ (Biochrom) and were
then treated with 0.05% trypsin/0.02% ethylenediamine tetraacetic acid
in phosphate-buffered saline at 37°C for 30 min. Trypsinization was
stopped by adding culture medium containing 10% heat-inactivated fetal
bovine serum. Cell pellets were separated by centrifugation (3000 r.p.m.,
3 min) and weighted; both pellets and supernatants were stored at ±20°C
until the extraction of retinoids.
Serum-free culture medium, as described above, was incubated with
10±7 M 13cRA or atRA and either no, 1 mg or 20 mg faf-BSA per ml
for 0±72 h and stored at ±20°C until the extraction of retinoids.
Solid-phase extraction and reversed-phase high performance liquid
chromatography were performed as described before (Collins et al, 1992;
Tzimas et al, 1994; Tsukada et al, 2000).
Cell proliferation Medium (200 ml per well) supplemented with
retinoids was added 1 d after seeding of 1 3 103 cells per well in 96-
well plates (Nunc, Wiesbaden, Germany). Sebocytes in medium
supplemented with dimethyl sulfoxide but without retinoids served as
controls. Medium with or without retinoids was changed every 3 d. Cell
proliferation was assessed by the 4-methyl umbelliferyl heptanoate
¯uorescence assay, as previously described (Akamatsu et al, 1993).
Statistical analysis Values represent the mean 6 SD. Three, sub-
sequent experiments of cell proliferation were performed in 6plicate
wells each time. Cellular retinoid concentration was assessed at least in
three subsequent experiments with a triplicate measurement performed
each time. Statistical signi®cance of the data was evaluated by the two-
sided Student's t test. Mean differences were considered to be signi®cant
when p < 0.05.
RESULTS
Stability of retinoic acids In preliminary experiments, the
stability of retinoic acids in culture medium not incubated with
cells was tested under the culture conditions used (0 mg per ml,
1 mg or 20 mg faf-BSA per ml, handling under dimmed yellow
light, maintenance at 37°C with 5% CO2 in darkness). 13cRA was
relatively stable up to 24 h with low levels of isomerization to atRA
(up to 10%). Incubation with 13cRA or atRA for 24 h or longer
led to higher levels of isomerization of 13cRA to atRA. Overall,
isomerization of 13cRA to atRA was essentially higher than vice
versa. The stability of retinoic acids was not in¯uenced by the faf-
BSA levels in the medium (Fig 1).
faf-BSA controls uptake and metabolism of 13cRA and
atRA in SZ95 sebocytes SZ95 sebocytes were treated with
13cRA (10±7 M) or atRA (10±7 M) in serum-free medium
containing 1 mg or 20 mg faf-BSA per ml for several time
periods up to 72 h. Medium containing 13cRA or atRA was added
to the cells and was removed immediately after addition to
determine the intracellular concentration of retinoic acids at 0 h.
Treatment with 13cRA in medium containing 20 mg faf-BSA per
ml resulted in a quick initial uptake and a constant intracellular
concentration between 100 and 170 nM over 24 h, which declined
thereafter (Fig 2A). In contrast, in the medium containing 1 mg
faf-BSA per ml, 13cRA concentration increased up to 400 nM
after 6 h of treatment.
Cell treatment with atRA in medium containing 20 mg faf-BSA
per ml also caused a controlled atRA uptake with constant
intracellular atRA concentrations between 500 and 1000 nM
between 3 and 72 h of treatment (Fig 2B). In contrast, atRA levels
increased up to 4000 nM at 3 and 6 h of atRA treatment in
medium containing 1 mg faf-BSA per ml.
The quick isomerization of 13cRA to atRA, which occurred
when the cells were treated with 13cRA in the culture medium
containing 1 mg faf-BSA per ml was not observed when the cells
were treated with 13cRA in medium containing 20 mg faf-BSA
per ml (Fig 3). In the latter case, atRA concentrations were
signi®cantly lower than those obtained in the experiments with
1 mg faf-BSA per ml over the entire treatment period, namely
reductions of 57% (38.3 6 12.5 nM/89.8 6 16.8 nM) at 0 h, 81%
(56.3 6 3.5 nM/294.8 6 60.5 nM) at 3 h, 89% (59.3 6 14.5
nM/541.0 6 69.5 nM) at 6 h, 88% (77.3 6 16.2 nM/661.0 6
157.1 nM) at 12 h, 87% (100.3 6 16.9 nM/760.7 6 135.7 nM)
at 24 h, 67% (162.3 6 29.8 nM/496.8 6 86.4 nM) at 48 h, and
29% (294.7 6 5.5 nM/411.3 6 55.9 nM) at 72 h were found.
Metabolism of atRA to 13cRA was constantly low in both
experimental settings (3±10%). No 9-cis retinoic acid could be
detected in any of the experiments performed (limit of detection
10 ng per ml).
faf-BSA abrogates the proliferation inhibitory effects of
retinoids on SZ95 sebocytes Proliferating SZ95 sebocytes
were treated for 9 d with either 13cRA (10-9±10-7 M) or atRA
(10-9±10-7 M) in serum-free medium containing 1 mg per ml or
20 mg faf-BSA per ml. Twenty milligrams of faf-BSA per ml
induced an inhibition of SZ95 sebocyte proliferation up to
60 6 4% in comparison with the cell growth rates obtained in
1 mg faf-BSA per ml. 13cRA and atRA exhibited a signi®cantly
concentration-dependent inhibition on SZ95 sebocyte prolifer
ation in medium containing 1 mg faf-BSA per ml (Fig 4). In
contrast, when SZ95 sebocytes were incubated with 13cRA or
atRA in medium containing 20 mg faf-BSA per ml no effect on
SZ95 sebocyte proliferation could be detected, even at high
retinoid concentrations (10±6 and 10±5 M).
DISCUSSION
Besides retinol, atRA and 13cRA are detectable as endogenous
retinoids in human plasma (De Leenheer et al, 1982; Napoli et al,
1985; Eckhoff and Nau, 1990; Tang and Russell, 1990).
Figure 1. Stability of retinoic acids. Concentrations of (A) 13cRA
0±72 h after addition of 13cRA, and (B) atRA 0±72 h after addition of
atRA to culture medium, not incubated with cells, containing 0 mg,
1 mg, or 20 mg faf-BSA per ml. The values are means of at least three
analyses. Error bars represent SD. *p < 0.05.
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Consequently, there are no major variances in gastrointestinal
absorption of retinoic acids (Wiegand and Chou, 1998) and no
obvious explanation for the individual variations of isotretinoin
absorption and response to a standard systemic 13cRA dose
(Brazzell et al, 1983; Orfanos and Zouboulis, 1998).
Interestingly, the formation of retinoid±albumin complexes were
not only shown to be the mode of bloodstream transportation of
atRA and 13cRA (Urien et al, 1994), but were also found to be
responsible for reduced cellular retinoid uptake and restricted anti-
proliferative effects on keratinocytes and epithelial cell lines (Avis
et al, 1995; Hodam and Creek, 1996; Mouawad et al, 1996). Our
results con®rmed a similar mechanism for reduced bioavailability of
13cRA, and of its active isomer atRA (Tsukada et al, 2000), in
human sebocytes. We showed that the presence of high BSA levels
in the medium and the probable binding of 13cRA and atRA to
BSA allowed for a rather controlled cellular uptake of retinoic acids
from the medium and for a reduced isomerization of 13cRA to
atRA. Blocking 13cRA±albumin interactions with a fatty acid
source has been shown to restore the biologic effects of 13cRA on
epithelial cells (Avis et al, 1995). This ®nding may explain the
improved clinical effect of 13cRA when administered during a
meal.
Although the intracellular retinoid levels at 48±72 h were similar
(atRA) or even slightly higher (13cRA) in the experiments with
high compared with those with low BSA medium content, the
anti-proliferative retinoid effect was abrogated in the study with
high BSA. These ®ndings indicate the signi®cance of free active
retinoid, in the present case atRA (Tsukada et al, 2000), for binding
the retinoic acid receptors and exerting their biologic effects. BSA
is itself active on epithelial cells with increasing concentrations
(Zouboulis et al, 1999b; this study), which indicates that BSA can
enter the cell. Obviously, BSA sequesters atRA from binding the
retinoic acid receptor and limits its activity (Avis et al, 1995). On
the other hand, these ®ndings con®rm a previous report on the
signi®cance of intracellular isomerization of 13cRA to atRA as a
speci®c retinoid mechanism on the biologic effects on human
sebocytes (Tsukada et al, 2000).
Figure 3. atRA/13cRA ratio in SZ95 sebocytes. The atRA/13cRA
ratio in SZ95 sebocytes 0±72 h after treatment with 10±7 M 13cRA in
serum-free medium containing 1 mg faf-BSA per ml (open bars) or
20 mg faf-BSA per ml (closed bars) represents the magnitude of
intracellular isomerization of 13cRA to atRA. The values are means of at
least three analyses. For statistical analysis the mean values were
compared at each time point. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 4. SZ95 sebocyte proliferation and retinoic acids. SZ95
sebocyte cultures were treated with 13cRA (A) or atRA (B) in serum-
free medium containing 1 mg faf-BSA per ml (open symbols) or 20 mg
faf-BSA per ml (closed symbols) for 9 d in the concentrations shown.
Cell proliferation was assessed in sixplicate wells by the 4-methyl
umbelliferyl heptanoate ¯uorescence assay. The results are presented in
percent of the controls. Values are mean 6 SD of three independent
experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 2. Retinoid metabolism in SZ95 sebocytes. (A) Intracellular
concentration of 13cRA after treatment of SZ95 sebocytes with 10±7 M
13cRA, and (B) intracellular concentration of atRA after SZ95 sebocyte
treatment of with 10±7 M atRA, for 0±72 h in serum-free medium
containing 1 mg faf-BSA per ml (open symbols) or 20 mg faf-BSA per
ml (closed symbols). The values are means of at least three analyses.
Error bars represent SD. *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001; *****p < 0.00001.
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In conclusion, this study provides evidence that the serum
albumin levels may play a crucial part in the uptake and the biologic
effects of systemic 13cRA on human sebaceous glands.
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